PT-141 10MG

Description

PT-141 10 mg is a synthetic cyclic research peptide, also known as Bremelanotide, intended for controlled laboratory and analytical investigation of melanocortin receptor systems. PT-141 is structurally related to alpha-melanocyte-stimulating hormone-derived peptide research and incorporates a cyclic peptide architecture that contributes to its receptor-interaction profile. It is commonly examined in peptide research involving melanocortin signaling, particularly MC3R and MC4R receptor pathways, ligand-receptor interactions, and receptor pharmacology.

Within structured laboratory peptide research, PT-141 10 mg may be evaluated in experimental models involving melanocortin receptor binding, receptor-mediated signaling, ligand-response characterization, cyclic peptide conformational research, comparative melanocortin peptide studies, molecular interaction analysis, and analytical method development. Its defined cyclic structure also provides a useful research model for examining how peptide modification and conformational constraint can influence receptor affinity, molecular stability, and signaling behavior under controlled non-clinical conditions.

NexBio supplies PT-141 10 mg as part of its peptide research supply catalog with an emphasis on clear product identification, research-only designation, batch traceability, and available analytical documentation. Researchers should review the applicable product label, batch identifier, stated specifications, and Certificate of Analysis where available before incorporating this laboratory research peptide into an established experimental protocol. Any reported purity, peptide identity, sequence, or analytical specification should be confirmed against documentation associated with the applicable batch.

Research Applications

PT-141 10 mg may be utilized in laboratory peptide research activities including:

• Melanocortin receptor signaling research
• MC3R-associated pathway investigation
• MC4R-associated pathway research
• Melanocortin ligand characterization
• Peptide-receptor interaction studies
• Receptor pharmacology research
• Ligand-response analysis
• Cyclic peptide structure-function studies
• Comparative melanocortin peptide characterization
• Molecular interaction research
• Analytical method development
• Controlled laboratory peptide research

Research applications may vary according to experimental design, analytical methodology, laboratory protocols, institutional requirements, research models, and individual study objectives.

Storage & Handling

To help maintain research material integrity:

• Store according to the conditions stated on the product label or applicable batch documentation.
• Keep PT-141 10 mg in its original labeled container until required for laboratory research.
• Protect from excessive heat, direct light, moisture, contamination, and unnecessary environmental exposure.
• Minimize repeated or unnecessary handling that could affect peptide integrity.
• Use appropriate laboratory techniques to reduce contamination risk.
• Maintain clear sample and batch identification throughout research workflows.
• Follow institutional safety procedures and product-specific documentation during storage and handling.

Quality Assurance

PT-141 10 mg is supplied under quality-focused procedures designed to support peptide identification, specification consistency, batch traceability, and research transparency. Applicable analytical review may include identity assessment, purity evaluation, cyclic peptide characterization, batch verification, and supporting laboratory documentation. A Certificate of Analysis (COA) or related batch-specific analytical record may be available for the applicable lot.

Any statement regarding purity percentage, peptide sequence, molecular identity, analytical methodology, or other testing specifications should be verified using the corresponding batch documentation.

Additional Information

Specification	Details
Product Name	PT-141 10 mg
Alternative Name	Bremelanotide
Product Type	Synthetic Cyclic Research Peptide
Presentation	10 mg
Peptide Classification	Melanocortin Receptor Research Peptide
Structural Class	Cyclic Peptide Analog
Primary Research Targets	Melanocortin Receptors, Including MC3R and MC4R
Research Classification	Research Use Only (RUO)
Research Category	Melanocortin Signaling and Receptor Pharmacology Research
Research Focus	Receptor Signaling, Ligand Response, Cyclic Peptide Structure, and Molecular Characterization
Related Research Entities	Bremelanotide, Alpha-MSH-Related Peptides, MC3R, MC4R, Melanocortin Signaling
Research Environment	Controlled Peptide Laboratory Research
Intended Use	Laboratory Research and Analytical Testing
Documentation	Batch Analytical Documentation Where Available

Research Use Disclaimer

FOR RESEARCH USE ONLY (RUO).

PT-141 10 mg is supplied exclusively for laboratory research, analytical testing, and scientific investigation purposes.

This product is not intended for human or veterinary administration, clinical use, therapeutic use, diagnosis, treatment, cure, mitigation, or prevention of any disease or medical condition.

This research material is not offered or represented by NexBio as a finished drug product, therapeutic treatment, dietary supplement, or consumer-use product. By purchasing this material, the buyer acknowledges that it is intended solely for appropriately controlled research environments and must be handled in accordance with applicable laboratory procedures, institutional requirements, product documentation, and laws.